Focus Stocks
Shares of Teva Hesitating?
Published on Wednesday, 25 August 2010 08:03 Written by Christopher Lynn
New York, August 25th (TradersHuddle.com) - Shares of Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) closed the trading
day lower by $0.28 or -0.56% from its previous close. Teva's shares price action formed what is considered to be a
doji close, where the open and close prices are very close to each other, mainly signaling an indecision between buyers and sellers.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis.
Teva's current stock range is defined by a trough, which marks calculated support at $46.99 and by a peak that marked the resistance point at $50.78. These levels are closely watched by traders managing their positions.
Traders wanting to establish a position in Teva or traders that are already holding the stock can use the doji close to their advantage, since the pattern present a short term pause in the stock's price action. This pause results in an entry point for traders depending of which way the stock resolves this short term indecision.
Doji are important candlesticks that provide information on their own and as components in a number of important patterns. Doji form when a security's open and close are virtually equal. The length of the upper and lower shadows can vary and the resulting candlestick looks like a cross, inverted cross or plus sign. Alone, doji are neutral patterns.
Any bullish or bearish bias is based on preceding price action and future confirmation. In the case of Teva, given that the stock finished the session lower, bears should monitor the stock, as it could reverse if it manages to trade above today's intraday high. Below a Doji illustration:

Related Articles
- Neutral Short Term Pattern on Teva
- ChromaDex Corp. Names Consumer Products Veteran Jeffrey Himmel CEO
- Teva to Report Fourth Quarter and Full Year 2011 Financial Results on February 15, 2012
- Teva to Present at the 30th Annual J.P. Morgan Healthcare Conference
- Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE®
- Teva Announces Management Succession
- Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe
- Teva Lower With High Volume
- Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68
- Teva Announces $3 billion Share Repurchase Program
Related Partner Headlines
- UPDATE: Morgan Stanley Downgrades Teva Pharmaceuticals to Equal-Weight - Benzinga
- Morgan Stanley Downgrades Teva Pharmaceutical to Equal-weight - Benzinga
- Teva Gets Upgrade on Revenue Growth - TheStreet.com
- Teva Pharmaceutical Industries Ltd Stock Upgraded (TEVA) - TheStreet.com
- Teva Taps Bristol-Myers' Levin as Next CEO - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Winner - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Winner - TheStreet.com
- Teva Stock To Go Ex-dividend Tomorrow (TEVA) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
HeidelbergCement Posts Rise In Q4 Operating Income - Benzinga -
Credit Suisse Posts Q4 Loss - Benzinga -
Stocks to Watch: Cisco, Groupon, Pepsi - TheStreet.com -
Rio Tinto Reports Decline In Fiscal-Year Net Profit - Benzinga -
General Growth Posts Narrower Q4 Loss - Benzinga -
Omnicom Lifts Quarterly Dividend By 20% - Benzinga -
Noble Group Names Jose Luiz Glaser As Agri-Unit CEO - Benzinga -
Telstra First-Half Profit Climbs 23% - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
Radware's Alteon® 10000 Earns INTERNET TELEPHONY® Magazine's Fourteenth Annual Product of the Year Award -
Empowered Products Wins XBIZ Award for Sexual Supplement Company of the Year -
CGGVeritas Announces Its Fourth Quarter and Full Year 2011 Results Conference Call March 1St,2012 -
Extensive Brines in Sand Rich Layers Intersected at International Lithium's Mariana Lithium-Potash Brine Project, Argentina -
China Digital TV to Announce Fourth Quarter and Full Year 2011 Financial Results on February 29, 2012 -
League of American Communications Professionals (LACP) Recognizes Healthyroads' Engage! Creative Group With Gold Magellan Award for Client/Member Communications -
Canadian Solar and HelioPower Complete 500 kW Solar Power System for Giumarra Vineyards Corporation -
Arcis Resources Corporation Signs Consulting Agreement With Certified Constructors Services, Inc.










